Literature DB >> 29719276

Improving influenza vaccines: challenges to effective implementation.

Fan Zhou1, Mai-Chi Trieu1, Richard Davies1, Rebecca Jane Cox2.   

Abstract

Influenza virus causes contagious respiratory illness and remains a major burden on healthcare systems and the economy. Seasonal influenza vaccine is the most cost-effective way to combat the disease. However, underestimation of disease severity and controversy over vaccine safety and effectiveness hampers public confidence in vaccination. Action is needed to restore public confidence and improve vaccine uptake. Tailoring seasonal influenza vaccines according to immune responsiveness and infection/vaccination history of different populations can improve vaccine efficacy and effectiveness. Steady progress has been made in next generation influenza vaccine designs aiming at broad and long-lasting protective immunity in pre-clinical and clinical studies. However, substantial research and regulatory effort is required before reaching the goal of a truly universal vaccine.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29719276     DOI: 10.1016/j.coi.2018.04.010

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  10 in total

1.  Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.

Authors:  James D Allen; Hyesun Jang; Joshua DiNapoli; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

2.  Mice with diverse microbial exposure histories as a model for preclinical vaccine testing.

Authors:  Jessica K Fiege; Katharine E Block; Mark J Pierson; Hezkiel Nanda; Frances K Shepherd; Clayton K Mickelson; J Michael Stolley; William E Matchett; Sathi Wijeyesinghe; David K Meyerholz; Vaiva Vezys; Steven S Shen; Sara E Hamilton; David Masopust; Ryan A Langlois
Journal:  Cell Host Microbe       Date:  2021-11-02       Impact factor: 21.023

3.  Tetramerizing tGCN4 domain facilitates production of Influenza A H1N1 M2e higher order soluble oligomers that show enhanced immunogenicity in vivo.

Authors:  Sweety Samal; Tripti Shrivastava; Praveen Sonkusre; Zaigham Abbas Rizvi; Rajesh Kumar; Shubbir Ahmed; Preeti Vishwakarma; Naveen Yadav; Manish Bansal; Kanchana Chauhan; Sebanta Pokhrel; Supratik Das; Padmakar Tambare; Amit Awasthi
Journal:  J Biol Chem       Date:  2020-08-13       Impact factor: 5.157

4.  Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study.

Authors:  Damien Foo; Mohinder Sarna; Gavin Pereira; Hannah C Moore; Annette K Regan
Journal:  PLoS Med       Date:  2022-04-05       Impact factor: 11.069

Review 5.  Innate Immune Cell Suppression and the Link With Secondary Lung Bacterial Pneumonia.

Authors:  David J Morgan; Joshua Casulli; Christine Chew; Emma Connolly; Sylvia Lui; Oliver J Brand; Rizwana Rahman; Christopher Jagger; Tracy Hussell
Journal:  Front Immunol       Date:  2018-12-14       Impact factor: 7.561

Review 6.  The Importance of Vaccinating Children and Pregnant Women against Influenza Virus Infection.

Authors:  Ravi S Misra; Jennifer L Nayak
Journal:  Pathogens       Date:  2019-11-26

Review 7.  Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement.

Authors:  Atin Khalaj-Hedayati; Caroline Lin Lin Chua; Peter Smooker; Khai Wooi Lee
Journal:  Influenza Other Respir Viruses       Date:  2019-11-27       Impact factor: 4.380

8.  Novel single-chain antibodies against highly conserved epitopes in the hemagglutinin of influenza A viruses: Promising agents for universal therapies.

Authors:  Samaneh Alizadeh; Setareh Moazen; Seyed Nooreddin Faraji; Afagh Moattari; Foroogh Nejatollahi
Journal:  Iran J Basic Med Sci       Date:  2021-01       Impact factor: 2.699

9.  Influenza Vaccines: Successes and Continuing Challenges.

Authors:  Tanja Becker; Husni Elbahesh; Leslie A Reperant; Guus F Rimmelzwaan; Albert D M E Osterhaus
Journal:  J Infect Dis       Date:  2021-09-30       Impact factor: 5.226

10.  Seasonal influenza vaccination in Kenya: an economic evaluation using dynamic transmission modelling.

Authors:  Jeanette Dawa; Gideon O Emukule; Edwine Barasa; Marc Alain Widdowson; Omu Anzala; Edwin van Leeuwen; Marc Baguelin; Sandra S Chaves; Rosalind M Eggo
Journal:  BMC Med       Date:  2020-08-20       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.